Global Gene Panel Market Overview:
Gene panel is a useful tool in clinical diagnosis, allows early therapeutic intervention, and makes a prognostic assessment of the disease. It is a technique in which several specific genes attached to a particular genetic problem are examined at the same time. A gene panel is a test that investigates multiple genes at once for cancer-associated mutations. It includes analyzing the genetic basis for an individual’s response to therapy. It offers a middle ground between sequencing just a single gene like BRCA1 that we are certain is involved in disease risk and sequencing every gene in the genome.
Global Gene Panel Market Insights
The global gene panel market is likely to grow at a significant CAGR over the forecast period,2020-2027. The major factors are the growing prevalence of chronic diseases with rising cases of cancers. Additionally, the increasing R&D investments and rising adaptation of gene panels will spur the global gene panel industry in future periods. Furthermore, the growing public-private funding for diagnostic panel activities and the easy development of customized panels is expected to witness remarkable growth of gene panel. The increasing usage of gene panels for the diagnosis of genetic disorders with the treatment of numerous diseases is expected to forecast the demand for gene panels over the coming years.
Moreover, the upsurge in demand for genetic testing for hereditary and somatic cancers positively impacts the market for gene panels in the healthcare industry. Furthermore, the rapidly expanding customer expectation, growth in the extensive R&D activities at the academic and industrial level, and increasing day by day scope of biomedical applications push the demand for the gene panel market. The growing applications of gene panels in genomic analysis for cancer research, biomarker discovery, and patient stratification for clinical discovery will bolster the growth of the global gene panel market share. Additionally, the growing geriatric population and increasing healthcare demands in the developing world making the growth of the gene panel market across the globe.
Growth Driver
Gene panels use next-generation sequencing technology as diagnostic tools that enable individualized cancer‐patient care. It offers sequencing of large genomic regions, high numbers of genes, or high numbers of samples in a single, efficient and cost-effective assay. The gene panel provides several benefits, including speed, scalability, saves time, and reduces costs associated with running multiple separate assays. In addition, Due to the advantages of large market size, low market concentration, and gradual maturity of technology applications, gene panela has attracted various enterprises to the layout. However, restrictions are often challenging to achieve. Also, the safety concerns associated with the genetic data are expected to be a restraint to the growth of the gene panel market.
Product & Services Segmental Analysis
The global gene panel market is segregated into testing kits and testing services based on the product and segment. The testing kits segment is estimated to witness the highest growth over the analysis timeframe due to the rise in adoption of gene panels in research activities, rising prevalence of chronic illness, and increasing demand for disease diagnosis.
The testing services will grow significantly due to the rising gene panel systems adoption, rising demand for cancer diagnosis, and rapid expansion in the customer base.
Technique Segmental Analysis
The global gene panel market is authorized into an amplicon-based approach and a hybridization-based approach based on the technique. The amplicon-based approach segment held for a significant market share in 2019 and will gain maximum market revenue by 2027. It is attributable to the widespread application for the discovery, validation, or screening of genetic variants. It reduces sequencing costs and turnaround time compared to broader approaches such as whole-genome sequencing.
The hybridization-based approach segment is poised to witness significant growth over the forecast period as it saves time and rising structural variation and single nucleotide polymorphisms detection.
Design Segmental Analysis
The global gene panel market is categorized into predesigned gene panels and customized gene panels based on the design. The customized gene panel segment held for a significant market share in 2019 and will witness to gain maximum market revenue by 2027. It is attributable to the widespread application of customized gene panels across the diagnostics and therapeutics sector and the rising number of clinical research studies.
The predesigned gene panel segment is poised to witness significant growth over the forecast period. It is convenient & allows researchers to focus on data generation, and analysis saves time and cost-effectiveness.
Application Segmental Analysis
The global gene panel market is classified into cancer risk assessment, diagnosis of congenital diseases, Pharmacogenetics, and other applications based on the application. The cancer risk assessments are expected to be the highest revenue share for the gene panel during the forecast period. The segment’s growth is primarily attributed to the increasing number of cancer and the rising demand for gene panels in cancer research and diagnosis.
Pharmacogenetics will witness a lucrative growth rate in the estimated period due to rising research in drug therapy and drug discovery and increasing demand for personalized medicine.
End-User Segmental Analysis
Based on the end-user, the global gene panel market is segmented into pharmaceutical and biotechnology companies, research and academic institutes, and hospital and diagnostic laboratories. The hospital &diagnostics laboratories segment will dominate the global gene panel market by 2027. Due to the rush in the number of hospitals & diagnostic centers using gene panels to diagnose cancer and other chronic conditions, economic expansion and government focus on broader healthcare policies.
The pharmaceuticals and biotechnology companies assigned for the largest share of the gene panel market in 2020 on account of the increasing use of panels in the clinical trial setting and controlled-release drugs.
Region Segmental Analysis
By geography, the global gene panel market is segmented into North America, Europe, Asia Pacific, South America, and The Middle East & Africa. North America is estimated to project considerable growth over 2020-2027. Due to growing research on cancer, the presence of leading industry players offering innovative products, and increasing healthcare expenditure.
The Asia Pacific will capture a definite share of the gene panel market by 2027. Due to the increasing genome research is continually improving health care infrastructure in the amphibious or airborne operation health care expenditures in emerging countries such as India and China.
Competitor Analysis
Companies such as Illumina Inc, GENEWIZ Inc, QIAGEN, Novogene Corporation, Agilent Technologies, Thermo Fisher Scientific, Eurofins Scientific, BGI, Integrated DNA Technologies, F. Hoffmann-La Roche AG, and GATC Biotech AG are the key players in the global gene panel market.
Key Stakeholders
- Market research and consulting firms
- Industry associations
- Global gene panel healthcare manufacturing firm
- Research organizations and consulting companies
- Organizations, associations, and alliances related to gene panel
- Regulatory bodies
- Suppliers
- Retailers
The objective of the research
- Market modeling starts with identifying a target market where historical data exists. A Market can include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our client deep dive into the market.
- Product analysis involves examining product features, costs, availability, quality, and other aspects. Product analysis is conducted to understand potential buyers and measure competition in the market.
- Market Trend and Economic Factors Analysis helps assess potential changes to an economy’s inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can or have a major effect on the target market.
- Market Segmental Analysis defines an in-depth scenario of the target market by grouping consumers into naturally existing created segments of consumers who share similar product preferences or characteristics.
- The geographical mapping approach helps our clients to understand national or international markets because different consumers in different regions have different needs, wants, and cultural characteristics that they can specifically target.
Market Modelling
By Product & Service
- Test Kits
- Testing Services
By Technique
- Amplicon-based Approach
- Hybridization-based Approach
By Design
- Predesigned Gene Panel
- Customized Gene Panel
By Application
- Cancer Risk Assessment
- Diagnosis of Congenital Diseases
- Pharmacogenetics
- Other Applications
By End-User
- Pharmaceutical and Biotechnology Companies
- Research and Academic Institutes
- Hospital and Diagnostic Laboratories
By Region
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
More Related Reports:
Global Pharmacy Automation Market
Global Genetic Toxicology Testing Market
Global Synthetic Stem Cells Market
Global High-Content Screening Market
Global Aseptic Sampling Market
Global Flow Cytometry Market
Global Stem Cell Banking Market
Global High Resolution Melting Analysis Market
Global Cell Culture Market
Global Bioreactors Market